Search Results - "Difrancesco, Robin"

Refine Results
  1. 1
  2. 2
  3. 3

    Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry by DiFrancesco, Robin, Griggs, Jennifer J., Donnelly, Julie, DiCenzo, Robert

    “…A method for the simultaneous determination of cyclophosphamide (CP), doxorubicin (dox), and doxorubicinol (dol) was developed and validated to analyze 400 μL…”
    Get full text
    Journal Article
  4. 4

    Interaction between buprenorphine and atazanavir or atazanavir/ritonavir by McCance-Katz, Elinore F, Moody, David E, Morse, Gene D, Ma, Qing, DiFrancesco, Robin, Friedland, Gerald, Pade, Patricia, Rainey, Petrie M

    Published in Drug and alcohol dependence (01-12-2007)
    “…Abstract Opioid addiction and HIV disease frequently co-occur. Adverse drug interactions have been reported between methadone and some HIV medications, but…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders by Bednasz, Cindy, Luque, Amneris E, Zingman, Barry S, Fischl, Margaret A, Gripshover, Barbara M, Venuto, Charles S, Gu, Jie, Feng, Zekun, DiFrancesco, Robin, Morse, Gene D, Ma, Qing

    Published in Current vascular pharmacology (01-05-2016)
    “…The use of combination antiretroviral therapy (cART) has significantly decreased the morbidity and mortality associated with human immunodeficiency virus (HIV)…”
    Get more information
    Journal Article
  7. 7
  8. 8

    2178 Drug development core facilitates institutional collaboration and translational science innovation by Morse, Gene, Puzanov, Igor, Gudkov, Andrei, DiFrancesco, Robin, Jusko, William, Ernstoff, Marc, Mohler, James, Murphy, Timothy, Bies, Robert

    “…OBJECTIVES/SPECIFIC AIMS: Drug development is a common research pursuit for basic and clinical scientists that interfaces diagnostic/therapeutic challenges…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Pharmacokinetic interactions of CEP-1347 and atazanavir in HIV-infected patients by Ma, Qing, Gelbard, Harris A., Maggirwar, Sanjay B., Dewhurst, Stephen, Gendelman, Howard E., Peterson, Derick R., DiFrancesco, Robin, Hochreiter, Jill S., Morse, Gene D., Schifitto, Giovanni

    Published in Journal of neurovirology (01-06-2013)
    “…CEP-1347 is a potent inhibitor of mixed lineage kinase (MLK), which was investigated for ameliorating HIV-associated neurocognitive disorders. CEP-1347 and…”
    Get full text
    Journal Article
  11. 11

    Inhibition of Atazanavir Oral Absorption by Lansoprazole Gastric Acid Suppression in Healthy Volunteers by Tomilo, Desiree L., Smith, Patrick F., Ogundele, Abayomi B., Difrancesco, Robin, Berenson, Charles S., Eberhardt, Ellana, Bednarczyk, Edward, Morse, Gene D.

    Published in Pharmacotherapy (01-03-2006)
    “…Study Objective. To determine whether the pharmacokinetics of atazanavir, a protease inhibitor used to treat human immunodeficiency virus (HIV) infection, are…”
    Get full text
    Journal Article
  12. 12

    Quality Assurance Program for Clinical Measurement of Antiretrovirals: AIDS Clinical Trials Group Proficiency Testing Program for Pediatric and Adult Pharmacology Laboratories by HOLLAND, Diane T, DIFRANCESCO, Robin, STONE, Judith, HAMZEH, Fayez, CONNOR, James D, MORSE, Gene D

    Published in Antimicrobial Agents and Chemotherapy (01-03-2004)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  13. 13

    Determination of protease inhibitors using liquid chromatography–tandem mass spectrometry by Frerichs, Valerie A, DiFrancesco, Robin, Morse, Gene D

    “…A method for the analysis of six protease inhibitors and one metabolite has been developed and validated. Amprenavir, ritonavir, saquinavir, lopinavir,…”
    Get full text
    Journal Article
  14. 14

    Compartmental Pharmacokinetic Analysis of Oral Amprenavir with Secondary Peaks by OKUSANYA, Olanrewaju, FORREST, Alan, DIFRANCESCO, Robin, BILIC, Sanela, ROSENKRANZ, Susan, PARA, Michael F, ADAMS, Elizabeth, YARASHESKI, Kevin E, REICHMAN, Richard C, MORSE, Gene D

    Published in Antimicrobial Agents and Chemotherapy (01-05-2007)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  15. 15

    Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma by KEIL, Kim, FRERICHS, Valerie A, DIFRANCESCO, Robin, MORSE, Gene

    Published in Therapeutic drug monitoring (01-06-2003)
    “…The increasing interest in applying therapeutic drug monitoring (TDM) to antiretroviral therapy is related to the observed interindividual variation in…”
    Get full text
    Journal Article
  16. 16

    Amprenavir and Efavirenz Pharmacokinetics before and after the Addition of Nelfinavir, Indinavir, Ritonavir, or Saquinavir in Seronegative Individuals by MORSE, Gene D, ROSENKRANZ, Susan, PARA, Michael F, SEGAL, Yoninah, DIFRANCESCO, Robin, ADAMS, Elizabeth, BRIZZ, Barbara, YARASHESKI, Kevin E, REICHMAN, Richard C

    Published in Antimicrobial Agents and Chemotherapy (01-08-2005)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  17. 17

    The Effects of Once-Daily Saquinavir/Minidose Ritonavir on the Pharmacokinetics of Methadone by Shelton, Mark J., Cloen, Denise, DiFrancesco, Robin, Berenson, Charles S., Esch, Andrew, de Caprariis, Pascal J., Palic, Branka, Schur, Jane L., Buggé, Christopher J. L., Ljungqvist, Anders, Espinosa, Orlando, Hewitt, Ross G.

    Published in Journal of clinical pharmacology (01-03-2004)
    “…Twelve methadone‐maintained HIV‐negative subjects were given saquinavir/ritonavir (SQV/rtv) 1600 mg/100 mg once daily for 14 days. Pharmacokinetic evaluations…”
    Get full text
    Journal Article
  18. 18

    Effects of Grapefruit Juice on Pharmacokinetic Exposure to Indinavir in HIV-Positive Subjects by Shelton, Mark J., Wynn, Heather E., Hewitt, Ross G., DiFrancesco, Robin

    Published in Journal of clinical pharmacology (01-04-2001)
    “…The objective of this study was to determine the effects of double‐strength grapefruit juice on gastric pH and systemic bioavailability of indinavir in…”
    Get full text
    Journal Article
  19. 19

    Development and validation of an assay to measure cannabidiol and Δ9-tetrahydrocannabinol in human EDTA plasma by UHPLC-MS/MS by Ocque, Andrew J., Hagler, Colleen E., DiFrancesco, Robin, Lombardo, Jeffrey, Morse, Gene D.

    “…The therapeutic use of cannabinoids has increased with providers often recommending cannabinoid-containing products with limited pre-clinical and clinical…”
    Get full text
    Journal Article
  20. 20

    Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspirates by Ocque, Andrew J., Hagler, Colleen E., DiFrancesco, Robin, Morse, Gene D., Talal, Andrew H.

    “…•UPLC–MS/MS method for measurement of DSV, DSVm1, OBV, PTV, and RTV in human liver FNA.•The method is validated with high accuracy and precision.•The method is…”
    Get full text
    Journal Article